Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protagonist Therapeutics (PTGX) Other Non Operating Income: 2016-2024

Historic Other Non Operating Income for Protagonist Therapeutics (PTGX) over the last 9 years, with Dec 2024 value amounting to $250,000.

  • Protagonist Therapeutics' Other Non Operating Income fell 76.60% to $33,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $182,000, marking a year-over-year decrease of 30.80%. This contributed to the annual value of $250,000 for FY2024, which is 224.38% up from last year.
  • Protagonist Therapeutics' Other Non Operating Income amounted to $250,000 in FY2024, which was up 224.38% from -$201,000 recorded in FY2023.
  • Protagonist Therapeutics' 5-year Other Non Operating Income high stood at $250,000 for FY2024, and its period low was -$585,000 during FY2020.
  • Moreover, its 3-year median value for Other Non Operating Income was -$80,000 (2022), whereas its average is -$10,333.
  • As far as peak fluctuations go, Protagonist Therapeutics' Other Non Operating Income tumbled by 58,400.00% in 2020, and later skyrocketed by 224.38% in 2024.
  • Protagonist Therapeutics' Other Non Operating Income (Yearly) stood at -$585,000 in 2020, then surged by 74.53% to -$149,000 in 2021, then soared by 46.31% to -$80,000 in 2022, then slumped by 151.25% to -$201,000 in 2023, then spiked by 224.38% to $250,000 in 2024.